{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:07:47Z","timestamp":1788815267934,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010411","name":"Een H\u00e4erz fir kriibskrank Kanner","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["370C-20220063"],"award-info":[{"award-number":["370C-20220063"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["370C-20250066"],"award-info":[{"award-number":["370C-20250066"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011017","name":"Recherches Scientifiques Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2011-0030001"],"award-info":[{"award-number":["2011-0030001"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["370C-20160062"],"award-info":[{"award-number":["370C-20160062"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118369","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:02:36Z","timestamp":1787007756000},"page":"118369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Gut microbiome crosstalk in acute myeloid leukemia: mechanisms, treatment-associated dysbiosis, and translational opportunities"],"prefix":"10.1016","volume":"253","author":[{"given":"Hyejun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118369_b0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MOH.0000000000000626","article-title":"Genetic heterogeneity and clonal evolution in acute myeloid leukemia","volume":"28","author":"Romer-Seibert","year":"2021","journal-title":"Curr. Opin. Hematol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0015","first-page":"3543","article-title":"Outcomes and genetic dynamics of acute myeloid leukemia at first relapse","volume":"109","author":"Bataller","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0025","first-page":"573","article-title":"Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity","volume":"160","author":"Aron-Wisnewsky","year":"2021","journal-title":"Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies, Gastroenterology"},{"issue":"6536","key":"10.1016\/j.bcp.2026.118369_b0030","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118369_b0035","doi-asserted-by":"crossref","unstructured":"T. Yu, F. Guo, Y. Yu, T. Sun, D. Ma, J. Han, Y. Qian, I. Kryczek, D. Sun, N. Nagarsheth, Y. Chen, H. Chen, J. Hong, W. Zou, J.Y. Fang, Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy, Cell 170(3) (2017) 548\u2013563 e16.","DOI":"10.1016\/j.cell.2017.07.008"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41698-025-01034-0","article-title":"The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review","volume":"9","author":"Bohm","year":"2025","journal-title":"npj Precis. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/1040841X.2025.2610215","article-title":"The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment","volume":"52","author":"Chan","year":"2026","journal-title":"Crit. Rev. Microbiol."},{"issue":"6371","key":"10.1016\/j.bcp.2026.118369_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.bcp.2026.118369_b0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.bcp.2026.118369_b0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0065","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1038\/s41467-021-23376-6","article-title":"Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients","volume":"12","author":"Malard","year":"2021","journal-title":"Nat. Commun."},{"issue":"34","key":"10.1016\/j.bcp.2026.118369_b0070","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1200\/JCO.22.02366","article-title":"Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML","volume":"41","author":"Rashidi","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.bcp.2026.118369_b0075","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/bloodadvances.2024015571","article-title":"Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial","volume":"9","author":"Malard","year":"2025","journal-title":"Blood Adv."},{"issue":"26","key":"10.1016\/j.bcp.2026.118369_b0080","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8066","key":"10.1016\/j.bcp.2026.118369_b0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-025-08938-8","article-title":"Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1","volume":"642","author":"Agarwal","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0095","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","article-title":"Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0100","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3324\/haematol.2023.284138","article-title":"Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia","volume":"109","author":"Potgens","year":"2024","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.bcp.2026.118369_b0105","doi-asserted-by":"crossref","first-page":"16431","DOI":"10.1002\/cam4.6283","article-title":"Alteration of gut microbiome and correlated amino acid metabolism are associated with acute myelocytic leukemia carcinogenesis","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236460","article-title":"Gut microbiota profiles of treatment-naive adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy","volume":"15","author":"Rattanathammethee","year":"2020","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.bcp.2026.118369_b0115","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1038\/s41388-022-02395-7","article-title":"Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients","volume":"41","author":"Zhao","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0120","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20230609","article-title":"Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line","volume":"43","author":"Hatta","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bcp.2026.118369_b0125","doi-asserted-by":"crossref","unstructured":"H. Ye, B. Adane, N. Khan, E. Alexeev, N. Nusbacher, M. Minhajuddin, B.M. Stevens, A.C. Winters, X. Lin, J.M. Ashton, E. Purev, L. Xing, D.A. Pollyea, C.A. Lozupone, N.J. Serkova, S.P. Colgan, C.T. Jordan, Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells, Cancer Cell 34(4) (2018) 659\u2013673 e6.","DOI":"10.1016\/j.ccell.2018.08.016"},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","article-title":"Short-chain fatty acids and cancer","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2026.118369_b0135","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/nu15092211","article-title":"Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0140","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bcp.2026.118369_b0145","article-title":"Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12916-022-02529-4","article-title":"Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis","volume":"20","author":"Alvandi","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.bcp.2026.118369_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590685","article-title":"Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0160","doi-asserted-by":"crossref","DOI":"10.1097\/BS9.0000000000000200","article-title":"Gut microbiota plays pivotal roles in benign and malignant hematopoiesis","volume":"6","author":"Li","year":"2024","journal-title":"Blood Sci."},{"key":"10.1016\/j.bcp.2026.118369_b0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2024.01.005","article-title":"Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity","volume":"213","author":"Wei","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118369_b0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","article-title":"Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model","volume":"30","author":"Chen","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12934-020-01477-z","article-title":"Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota","volume":"20","author":"Nakkarach","year":"2021","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.bcp.2026.118369_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124299","article-title":"The optimization and validation of a gas chromatography-mass spectrometry method to analyze the concentration of acetate, propionate and butyrate in human plasma or serum","volume":"1247","author":"Vandermeulen","year":"2024","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bcp.2026.118369_b0185","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241309755","article-title":"Oral supplementation with propionate is reflected in the serum of healthy individuals","volume":"18","author":"Schroder","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-021-02128-w","article-title":"The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?","volume":"40","author":"Ma","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0195","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat. Commun."},{"issue":"6575","key":"10.1016\/j.bcp.2026.118369_b0200","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"issue":"6264","key":"10.1016\/j.bcp.2026.118369_b0205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.bcp.2026.118369_b0210","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","article-title":"The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"Brown","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.bcp.2026.118369_b0215","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.M301403200","article-title":"Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation","volume":"278","author":"Le Poul","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0220","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-291X(03)00488-1","article-title":"Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids","volume":"303","author":"Nilsson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2026.118369_b0225","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","article-title":"GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon","volume":"69","author":"Thangaraju","year":"2009","journal-title":"Cancer Res."},{"issue":"7480","key":"10.1016\/j.bcp.2026.118369_b0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"issue":"7480","key":"10.1016\/j.bcp.2026.118369_b0235","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0240","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","article-title":"Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function","volume":"17","author":"Kelly","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"7268","key":"10.1016\/j.bcp.2026.118369_b0245","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"issue":"6145","key":"10.1016\/j.bcp.2026.118369_b0255","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.118369_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102452","article-title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization","volume":"56","author":"Liu","year":"2022","journal-title":"Redox Biol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118369_b0270","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage Polarization States in the Tumor Microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5418","key":"10.1016\/j.bcp.2026.118369_b0275","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"5418","key":"10.1016\/j.bcp.2026.118369_b0280","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0285","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0290","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2026.118369_b0295","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","article-title":"Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system","volume":"41","author":"Ala","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.bcp.2026.118369_b0300","doi-asserted-by":"crossref","unstructured":"K. Hezaveh, R.S. Shinde, A. Klotgen, M.J. Halaby, S. Lamorte, M.T. Ciudad, R. Quevedo, L. Neufeld, Z.Q. Liu, R. Jin, B.T. Grunwald, E.G. Foerster, D. Chaharlangi, M. Guo, P. Makhijani, X. Zhang, T.J. Pugh, D.M. Pinto, I.L. Co, A.P. McGuigan, G.H. Jang, R. Khokha, P.S. Ohashi, G.M. O'Kane, S. Gallinger, W.W. Navarre, H. Maughan, D.J. Philpott, D.G. Brooks, T.L. McGaha, Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity, Immunity 55(2) (2022) 324\u2013340 e8.","DOI":"10.1016\/j.immuni.2022.01.006"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0305","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2409209","article-title":"The role of microbial indole metabolites in tumor","volume":"16","author":"Jia","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bcp.2026.118369_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109690","article-title":"The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases","volume":"239","author":"Zhou","year":"2023","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.bcp.2026.118369_b0315","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","article-title":"The gut microbiota in cancer immunity and immunotherapy","volume":"22","author":"Xie","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bcp.2026.118369_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111495","article-title":"Fusobacterium nucleatum-derived 3-indolepropionic acid promotes colorectal cancer progression via aryl hydrocarbon receptor activation in macrophages","volume":"414","author":"Song","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.118369_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.705583","article-title":"The Capacity to Produce Hydrogen Sulfide (H(2)S) via Cysteine Degradation Is Ubiquitous in the Human Gut Microbiome","volume":"12","author":"Braccia","year":"2021","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118369_b0330","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s42255-023-00854-3","article-title":"Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota","volume":"5","author":"Ji","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.bcp.2026.118369_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105119","article-title":"Hydrogen sulfide: An endogenous regulator of the immune system","volume":"161","author":"Dilek","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0340","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf065","article-title":"Hypoxia-activated cystathionine beta-synthase\/H2S signaling drives drug resistance in acute myeloid leukemia through CD36-mediated fatty acid metabolism","volume":"117","author":"Li","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118369_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111236","article-title":"Exploring the impact of hydrogen sulfide on hematologic malignancies: A review","volume":"120","author":"Lou","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.118369_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127871","article-title":"Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications","volume":"288","author":"Yin","year":"2024","journal-title":"Microbiol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0360","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037114","article-title":"The correlation between gut microbiota and both neurotransmitters and mental disorders: A narrative review","volume":"103","author":"Mhanna","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116434","article-title":"Identification of human gut bacteria that produce bioactive serotonin and promote colonic innervation","volume":"44","author":"Moretti","year":"2025","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0370","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.7150\/thno.55986","article-title":"Role of serotonin receptor signaling in cancer cells and anti-tumor immunity","volume":"11","author":"Karmakar","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/cid\/ciz777","article-title":"Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia","volume":"71","author":"Galloway-Pena","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"14","key":"10.1016\/j.bcp.2026.118369_b0380","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/cncr.30039","article-title":"The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia","volume":"122","author":"Galloway-Pena","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0385","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1800897","article-title":"Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening","volume":"12","author":"Hueso","year":"2020","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0390","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.clnu.2023.09.021","article-title":"Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss","volume":"42","author":"Potgens","year":"2023","journal-title":"Clin. Nutr."},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0395","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/bloodadvances.2021006783","article-title":"Lasting shift in the gut microbiota in patients with acute myeloid leukemia","volume":"6","author":"Rashidi","year":"2022","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0400","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0405","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/hematology.2020000098","article-title":"Updates in infection risk and management in acute leukemia","volume":"2020","author":"Logan","year":"2020","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"14","key":"10.1016\/j.bcp.2026.118369_b0410","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-017-0409-1","article-title":"Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients","volume":"9","author":"Galloway-Pena","year":"2017","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118369_b0420","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70501","article-title":"Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients","volume":"14","author":"Salvestrini","year":"2025","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0425","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40164-025-00661-4","article-title":"Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses","volume":"14","author":"Kapandji","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118369_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.848580","article-title":"Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients","volume":"12","author":"Franklin","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7762","key":"10.1016\/j.bcp.2026.118369_b0435","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"issue":"7698","key":"10.1016\/j.bcp.2026.118369_b0440","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"issue":"6005","key":"10.1016\/j.bcp.2026.118369_b0445","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace","year":"2010","journal-title":"Science"},{"issue":"6356","key":"10.1016\/j.bcp.2026.118369_b0450","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bcp.2026.118369_b0455","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0460","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.leukres.2005.08.023","article-title":"Transcriptional and post-transcriptional regulation of glutathione S-transferase P1 expression during butyric acid-induced differentiation of K562 cells","volume":"30","author":"Schnekenburger","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcp.2026.118369_b0465","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0470","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bcp.2010.11.011","article-title":"Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway","volume":"81","author":"Chateauvieux","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0475","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0480","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-017-02651-5","article-title":"Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases","volume":"9","author":"Fellows","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0485","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","article-title":"Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression","volume":"7","author":"Nshanian","year":"2025","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0490","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.molcel.2016.10.025","article-title":"Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues","volume":"64","author":"Krautkramer","year":"2016","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0495","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(19)30030-4","article-title":"An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study","volume":"6","author":"Savona","year":"2019","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0500","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.2019004143","article-title":"Oral cedazuridine\/decitabine for MDS and CMML: a phase 2 pharmacokinetic\/pharmacodynamic randomized crossover study","volume":"136","author":"Garcia-Manero","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118369_b0505","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"issue":"48","key":"10.1016\/j.bcp.2026.118369_b0510","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211230119","article-title":"Reactive granulopoiesis depends on T-cell production of IL-17A and neutropenia-associated alteration of gut microbiota","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0515","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.1400762","article-title":"Microbiota-derived compounds drive steady-state granulopoiesis via MyD88\/TICAM signaling","volume":"193","author":"Balmer","year":"2014","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0520","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/dc19-2533","article-title":"Microbiota-Related Metabolites and the Risk of Type 2 Diabetes","volume":"43","author":"Vangipurapu","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0525","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1136\/gutjnl-2020-323314","article-title":"Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health","volume":"70","author":"Brial","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0530","article-title":"Gut microbiome and chemotherapy-induced cardiotoxicity: A systematic review of evidence and emerging therapies, World","volume":"16","author":"Abdulaal","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118369_b0535","first-page":"cvag146","article-title":"The gut-heart axis in cardio-oncology","author":"Chan","year":"2026","journal-title":"Cardiovasc. Res."},{"issue":"21","key":"10.1016\/j.bcp.2026.118369_b0540","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E.coli Bacteremia Transmitted by Fecal Microbiota Transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6529","key":"10.1016\/j.bcp.2026.118369_b0545","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.bcp.2026.118369_b0550","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bcp.2026.118369_b0555","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Maleki Vareki, Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0560","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41409-020-01130-8","article-title":"PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation","volume":"56","author":"Qian","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.bcp.2026.118369_b0565","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.118369_b0570","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bcp.2026.118369_b0575","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/nm.4380","article-title":"The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease","volume":"23","author":"Legoff","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118369_b0580","first-page":"0658","article-title":"Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics","volume":"8","author":"Fang","year":"2025","journal-title":"Research (Wash D C)"},{"issue":"6757","key":"10.1016\/j.bcp.2026.118369_b0585","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.adu8000","article-title":"Controlled colonization of the human gut with a genetically engineered microbial therapeutic","volume":"389","author":"Whitaker","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118369_b0590","doi-asserted-by":"crossref","unstructured":"C.R. Gurbatri, G.A. Radford, L. Vrbanac, J. Im, E.M. Thomas, C. Coker, S.R. Taylor, Y. Jang, A. Sivan, K. Rhee, A.A. Saleh, T. Chien, F. Zandkarimi, I. Lia, T.R.M. Lannagan, T. Wang, J.A. Wright, H. Kobayashi, J.Q. Ng, M. Lawrence, T. Sammour, M. Thomas, M. Lewis, L. Papanicolas, J. Perry, T. Fitzsimmons, P. Kaazan, A. Lim, A.M. Stavropoulos, D.A. Gouskos, J. Marker, C. Ostroff, G. Rogers, N. Arpaia, D.L. Worthley, S.L. Woods, T. Danino, Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia, Nat Commun 15(1) (2024) 646.","DOI":"10.1038\/s41467-024-44776-4"},{"key":"10.1016\/j.bcp.2026.118369_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116412","article-title":"Probiotic therapeutics: A critical review of mechanisms, clinical efficacy, and the frontier of precision microbiome modulation","volume":"175","author":"Ashaolu","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118369_b0600","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118369_b0605","first-page":"506","article-title":"Expert consensus document","volume":"11","author":"Hill","year":"2014","journal-title":"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastroenterol Hepatol"},{"issue":"6264","key":"10.1016\/j.bcp.2026.118369_b0610","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118369_b0615","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2023.11.027","article-title":"The role of gut microbiota and metabolites in cancer chemotherapy","volume":"64","author":"Li","year":"2024","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0620","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11040896","article-title":"Lactobacillus Bacteremia and Probiotics: A Review","volume":"11","author":"Kullar","year":"2023","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.bcp.2026.118369_b0625","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3201\/eid2708.210018","article-title":"Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements","volume":"27","author":"Rannikko","year":"2021","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0630","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/380455","article-title":"Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG","volume":"38","author":"Salminen","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0635","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7326\/M18-0343","article-title":"Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review","volume":"169","author":"Bafeta","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.bcp.2026.118369_b0640","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/nu9121361","article-title":"Prebiotic Dietary Fiber and Gut Health: Comparing the in Vitro Fermentations of Beta-Glucan, Inulin and Xylooligosaccharide","volume":"9","author":"Carlson","year":"2017","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0645","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0650","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.3390\/nu7115459","article-title":"Definition of the Mediterranean Diet; a Literature Review","volume":"7","author":"Davis","year":"2015","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0655","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/nqac175","article-title":"Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial","volume":"116","author":"Seethaler","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0660","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/ajcn\/nqaa083","article-title":"Association between Mediterranean diet adherence and colorectal cancer: a dose-response meta-analysis","volume":"111","author":"Zhong","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.bcp.2026.118369_b0665","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clnu.2023.02.012","article-title":"Mediterranean diet and risk of breast cancer: An umbrella review","volume":"42","author":"Gonzalez-Palacios Torres","year":"2023","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.bcp.2026.118369_b0670","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00394-020-02346-6","article-title":"An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer","volume":"60","author":"Morze","year":"2021","journal-title":"Eur. J. Nutr."},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0675","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jamaoncol.2022.7753","article-title":"Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma","volume":"9","author":"Bolte","year":"2023","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0680","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101063","article-title":"Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis","volume":"9","author":"Schwingshackl","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118369_b0685","doi-asserted-by":"crossref","unstructured":"H.C. Wastyk, G.K. Fragiadakis, D. Perelman, D. Dahan, B.D. Merrill, F.B. Yu, M. Topf, C.G. Gonzalez, W. Van Treuren, S. Han, J.L. Robinson, J.E. Elias, E.D. Sonnenburg, C.D. Gardner, J.L. Sonnenburg, Gut-microbiota-targeted diets modulate human immune status, Cell 184(16) (2021) 4137\u20134153 e14.","DOI":"10.1016\/j.cell.2021.06.019"},{"key":"10.1016\/j.bcp.2026.118369_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100943","article-title":"Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice","volume":"45","author":"Fang","year":"2023","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.bcp.2026.118369_b0695","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","article-title":"Methionine metabolism in health and cancer: a nexus of diet and precision medicine","volume":"19","author":"Sanderson","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2026.118369_b0700","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tem.2024.01.009","article-title":"Dietary methionine restriction in cancer development and antitumor immunity","volume":"35","author":"Ji","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.bcp.2026.118369_b0705","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood.2023021380","article-title":"CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis","volume":"143","author":"Renga","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0710","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00280-021-04385-0","article-title":"Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota","volume":"89","author":"Liu","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118369_b0715","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms","volume":"19","author":"Cani","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0720","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bcp.2026.118369_b0725","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/2211-5463.13193","article-title":"Profiling of gut microbial dysbiosis in adults with myeloid leukemia","volume":"11","author":"Yu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bcp.2026.118369_b0730","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1559033","article-title":"Significant changes in gut microbiota and SCFAs among patients with newly diagnosed acute myeloid leukemia","volume":"16","author":"An","year":"2025","journal-title":"Front. Microbiol."},{"issue":"15","key":"10.1016\/j.bcp.2026.118369_b0735","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.3390\/ijms25158026","article-title":"Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients","volume":"25","author":"Kulecka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118369_b0740","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13068-024-02539-9","article-title":"Propionate production by Bacteroidia gut bacteria and its dependence on substrate concentrations differs among species","volume":"17","author":"Doring","year":"2024","journal-title":"Biotechnol Biofuels Bioprod"},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0745","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ecco-jcc\/jjaa248","article-title":"Gut Microbiota-Derived Propionate Production May Explain Beneficial Effects of Intermittent Fasting in Experimental Colitis","volume":"15","author":"Su","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bcp.2026.118369_b0750","article-title":"Butyrate producers, \u201cThe Sentinel of Gut\u201d: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2026.118369_b0755","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2026.1761627","article-title":"A genomic atlas of gut clostridia: phylogeny, butyrate, and propionate production","volume":"17","author":"Sola","year":"2026","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118369_b0760","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02292-23","article-title":"Fusobacterium nucleatum and its metabolite hydrogen sulfide alter gut microbiota composition and autophagy process and promote colorectal cancer progression","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.bcp.2026.118369_b0765","doi-asserted-by":"crossref","first-page":"G125","DOI":"10.1152\/ajpgi.00261.2020","article-title":"Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa","volume":"320","author":"Blachier","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2026.118369_b0770","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fmicb.2018.00983","article-title":"Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil\/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model","volume":"9","author":"Chang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118369_b0775","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603990","article-title":"Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study","volume":"97","author":"Osterlund","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118369_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109131","article-title":"Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein","volume":"325","author":"Ronis","year":"2020","journal-title":"Chem. Biol. Interact."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:13:59Z","timestamp":1788812039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":156,"alternative-id":["S0006295226007082"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118369","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome crosstalk in acute myeloid leukemia: mechanisms, treatment-associated dysbiosis, and translational opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118369"}}